We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Event

Webinar On Managing the FDA form "483": Inspection Observations

This webinar is a complete guide on how to manage the FDA's 483 observations during and after an inspection. How you respond can make or break you.

Description : This webinar is a complete guide on how to manage the FDA's 483 observations during and after an inspection. How you respond can make or break you.Form FDA 483 is a list of observations made by FDA during an inspection.  Observations are not a good thing. At the conclusion of an inspection, the FDA investigator lists specific examples that demonstrate an apparent violation of the applicable FDA regulations. You and the FDA investigator will discuss what the investigator found. At that point you are put on notice about your problems. You are warned that if you fail to correct the problems, it may result in further action by the FDA, such as levying civil money penalties, seizure, injunction, and/or prosecution. Firms are well advised to take the written 483 observations and FDA’s verbal warning seriously. A failure to promptly respond in writing to the FDA makes the situation even worse. As an immediate business consequence, marketing departments should expect competitors to show customers your 483.  Your 483 is used against you as a bad report.Prior to an inspection, the FDA investigator reviews your prior 483s and checks to make sure you corrected your previous problems. You will be held accountable for your prior response. What you promised to correct and what you did not correct becomes a critical factor in how FDA classifies your firm. What you fail to correct may lay for the foundation for long-term serious consequences with FDA. Your firm’s management is held accountable for its failure to adequately correct its regulatory problems. In some cases, the FDA will hold senior executive management personally liable for their managerial actions or inaction. Again, what a firm promises and what a firm does in response to a 483 makes a real difference.Areas Covered in the Session :What the Form FDA “483” meansHow to manage the FDA’s 483 observations during and after an inspectionWhat the FDA considers importantHow to respond effectively to 483 observationsPlanning for other problemsLearn how to manage your regulatory profile with the FDAWho Will Benefit:Regulatory Affairs ProfessionalsIn-house Legal CounselSenior Managers for Manufacturing and Quality AssuranceFDA consultantsSenior Operations and Finance ExecutivesPublic Relations ProfessionalsSenior Executive ManagementMarketingPrice tags:LiveSingle Live : For One Participant$ 249Corporate Live : For Max. 10 Participants$ 899RecordingSingle REC : For One Participant - Unlimited Access for 6 Months$ 299For more information and enquiries contact us atCompliance Trainings5939 Candlebrook Ct, Mississauga, ON L5V 2V5, Canada  Customer Support : #416-915-4458 

When

12 May 2015 @ 01:00 pm

12 May 2015 @ 02:00 pm

Duration: 1 hours

Timezone: GMT -5:00


Where

Online Webinar


Language

Englishen


Organised by

Compliance Trainings (deactivated)

Premium Events in Science

Other Events in Science

Similar Webinars in Science

BioFIT 2021

France, , 7 Dec 2021

Recent Publications in Science

Recent Videos in Science

Recent Speakers in Science

John Robert Zibert
Chief Medical Officer

1

Camille Thornton
founder

1

John N Zorich
Statistical Consultant & Trainer

4

Sponsors in Science

Recent News in Science

Annual report on the ERC activities and achievements in 2020

@https://erc.europa.eu/content/annual-report-erc-activities-and-achievements-2020 - 15 Apr 2021 07:22

Annual report on the ERC activities and achievements in 2020

@https://erc.europa.eu/content/annual-report-erc-activities-and-achievements-2020 - 15 Apr 2021 07:22

A milestone to be proud of: 100 million vaccinations in the 🇪🇺 EU. Vaccine delivery is also picking up speed: ✅1… https://t.co/kfvdckCtXO

@EU_ScienceHub - 14 Apr 2021 23:17

Premium EventsLearn more ..